NGB stands for Next Generation Bioprinting.
NGB is now much more than a platform name. For several years, it has been the technology foundation on which we develop our bioprinting solutions.
The market is moving fast. Having proven its potential for research, bioprinting is increasingly moving toward translational and clinical applications.
With the NGB-R® for research and the NGB-C® for GMP and clinical environments, we have designed a platform built to support this evolution.
NGB stands for Next Generation Bioprinting.
These three words reflect our conviction that bioprinting is entering a new stage today and taking its full place in biofabrication, set to contribute tomorrow to the development of innovative therapeutic solutions.
This new name is therefore less a change than an alignment between our identity, our technology and our ambition.
Welcome to NGB Biosystems.